HSC takes 24.7% gains on Tianyin Pharmaceutical (AMEX:TPI)
Today's Financial News - Posted November 17, 2009
TFN’s premier China pharma “Proxy Stock” Tianyin Pharmaceutical (AMEX:TPI) is doing everything right. Still, we’ve watched our gains getting whittled down to half of what they were two months ago. Time to take what’s left and get out of Dodge…
by J. Christoph Amberger
Baltimore, MD — TFN: I’ve just about had it with our premier China Proxy Stock, Tianyin Pharmaceutical (AMEX:TPI).
We took 51% gains on the first half of our position on 09/03/2009 — and have been watching the stock decline ever since.
There’s absolutely no good reason for this: Q1 2010 revenue increased 40.2% to $13.4 million, net income’s up 22.3% to $2.2 million with EPS of $0.08 vs. $0.07 last year. Q1 cashflow over last year’s up an incredible 345%.
In other words: Great company! But the price keeps dropping.
Right now, we’re still up 24.7%. I say let’s take that off the table and call it a day.
Sell Tianyin Pharmaceutical (AMEX:TPI) above $3.25.
This is double-digit gainer #69 of Hot Stock Confidential Members so far this year. Find out how they did it…
Next Article: TFN eNews 11/17/2009: The Okies are heading back to the Dust Bowl
Be the first to leave a reply.
Your comments are welcome

